158 related articles for article (PubMed ID: 36599466)
21. [Lymphangioleiomyomatosis].
Wirtz H
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S59-74; quiz 75-6. PubMed ID: 24277558
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Lymphangioleiomyomatosis originates in the pleural mesothelial cell population.
Clements D; Miller S; Johnson SR
Med Hypotheses; 2020 Aug; 141():109703. PubMed ID: 32276237
[TBL] [Abstract][Full Text] [Related]
23. The vitamin D binding protein axis modifies disease severity in lymphangioleiomyomatosis.
Miller S; Coveney C; Johnson J; Farmaki AE; Gupta N; Tobin MD; Wain LV; McCormack FX; Boocock DJ; Johnson SR
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30093573
[TBL] [Abstract][Full Text] [Related]
24. Lymphangioleiomyomatosis - a wolf in sheep's clothing.
Henske EP; McCormack FX
J Clin Invest; 2012 Nov; 122(11):3807-16. PubMed ID: 23114603
[TBL] [Abstract][Full Text] [Related]
25. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.
Goncharova EA; Krymskaya VP
J Cell Biochem; 2008 Feb; 103(2):369-82. PubMed ID: 17541983
[TBL] [Abstract][Full Text] [Related]
27. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
28. [Current understanding and perspectives of lymphangioleiomyomatosis].
Seyama K; Ando K; Hoshika Y; Suzuki Y; Takekawa H
Nihon Rinsho; 2013 Jun; 71(6):1103-8. PubMed ID: 23855221
[TBL] [Abstract][Full Text] [Related]
29. A genome-wide association study implicates
Kim W; Giannikou K; Dreier JR; Lee S; Tyburczy ME; Silverman EK; Radzikowska E; Wu S; Wu CL; Henske EP; Hunninghake G; Carel H; Roman A; Pujana MA; Moss J; Won S; Kwiatkowski DJ
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 31000673
[TBL] [Abstract][Full Text] [Related]
30. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target.
Abdelwahab EMM; Pal S; Kvell K; Sarosi V; Bai P; Rue R; Krymskaya V; McPhail D; Porter A; Pongracz JE
Oncogene; 2019 Apr; 38(16):3093-3101. PubMed ID: 30573768
[TBL] [Abstract][Full Text] [Related]
32. Progesterone and estradiol synergistically promote the lung metastasis of tuberin-deficient cells in a preclinical model of lymphangioleiomyomatosis.
Sun Y; Zhang E; Lao T; Pereira AM; Li C; Xiong L; Morrison T; Haley KJ; Zhou X; Yu JJ
Horm Cancer; 2014 Oct; 5(5):284-98. PubMed ID: 25069840
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological targeting of VEGFR signaling with axitinib inhibits Tsc2-null lesion growth in the mouse model of lymphangioleiomyomatosis.
Atochina-Vasserman EN; Abramova E; James ML; Rue R; Liu AY; Ersumo NT; Guo CJ; Gow AJ; Krymskaya VP
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1447-54. PubMed ID: 26432869
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.
Juvet SC; McCormack FX; Kwiatkowski DJ; Downey GP
Am J Respir Cell Mol Biol; 2007 Apr; 36(4):398-408. PubMed ID: 17099139
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary lymphangioleiomyomatosis with or without tuberous sclerosis].
Urban T
Rev Mal Respir; 2007 Jun; 24(6):725-40. PubMed ID: 17632432
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
38. Lung transplantation for lymphangioleiomyomatosis.
Warrior K; Dilling DF
J Heart Lung Transplant; 2023 Jan; 42(1):40-52. PubMed ID: 36334961
[TBL] [Abstract][Full Text] [Related]
39. Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.
Krymskaya VP
Proc Am Thorac Soc; 2008 Jan; 5(1):119-26. PubMed ID: 18094094
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis.
Bittmann I; Rolf B; Amann G; Löhrs U
Hum Pathol; 2003 Jan; 34(1):95-8. PubMed ID: 12605373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]